APA

Acosta A., Camilleri M., Shin A., Linker Nord S., O'Neill J., Gray A. V., Lueke A. J., Donato L. J., Burton D. D., Szarka L. A., Zinsmeister A. R., Golden P. L. & Fodor A. (20160527). Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome. : Clinical and translational gastroenterology.

Chicago

Acosta Andrés, Camilleri Michael, Shin Andrea, Linker Nord Sara, O'Neill Jessica, Gray Amber V, Lueke Alan J, Donato Leslie J, Burton Duane D, Szarka Lawrence A, Zinsmeister Alan R, Golden Pamela L and Fodor Anthony. 20160527. Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome. : Clinical and translational gastroenterology.

Harvard

Acosta A., Camilleri M., Shin A., Linker Nord S., O'Neill J., Gray A. V., Lueke A. J., Donato L. J., Burton D. D., Szarka L. A., Zinsmeister A. R., Golden P. L. and Fodor A. (20160527). Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome. : Clinical and translational gastroenterology.

MLA

Acosta Andrés, Camilleri Michael, Shin Andrea, Linker Nord Sara, O'Neill Jessica, Gray Amber V, Lueke Alan J, Donato Leslie J, Burton Duane D, Szarka Lawrence A, Zinsmeister Alan R, Golden Pamela L and Fodor Anthony. Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome. : Clinical and translational gastroenterology. 20160527.